U.S. Health Secretary Robert F. Kennedy Jr. has signed a new charter for the CDC's Advisory Committee on Immunization Practices (ACIP), broadening the panel's focus to include vaccine risks and alleged gaps in vaccine safety research. The charter, signed on March 31 and publicly posted shortly after, comes following a federal court ruling that challenged the legitimacy of Kennedy's previously reconstituted vaccine panel.
Last month, Boston-based U.S. District Judge Brian Murphy ruled that ACIP had been unlawfully restructured after Kennedy removed all 17 independent vaccine experts from the panel in 2024, replacing them with individuals who largely share his controversial stance on vaccine safety. The court placed the new panel's decisions on hold, prompting the latest charter revision.
The updated charter expands membership eligibility beyond traditional vaccine research and immunization expertise to now include specialists in toxicology, data science, and vaccine safety assessment. Critics argue the revised language — replacing stricter qualifications with the broader term "knowledgeable" — lowers the bar for panel membership and could make future legal challenges more difficult to sustain. Dorit Reiss, a vaccine policy law professor at UC Law San Francisco, raised this concern publicly.
The new charter also adds four non-voting liaison organizations, three of which — the Association of American Physicians and Surgeons, the Independent Medical Alliance, and Physicians for Informed Consent — have publicly expressed anti-vaccine positions. A fourth group, the Medical Academy of Pediatrics and Special Needs, advocates for children with autism, a condition Kennedy has repeatedly and falsely linked to childhood vaccines despite overwhelming scientific consensus to the contrary.
An HHS spokesperson described the charter renewal as routine and denied it signals any broader policy change. However, former CDC official Daniel Jernigan warned the move further politicizes vaccine guidance, while the American Academy of Pediatrics has not ruled out a legal challenge to the restructured panel.


Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
U.S. Launches Trade Investigation Into Germany’s Pharmaceutical Cost-Cutting Plans
Why the future of marijuana legalization remains hazy despite high public support
Australia Plans Higher Fines for Social Media Firms Failing to Block Underage Users
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
Taiwan Coast Guard Officer Finds Strength in Faith as China Increases Pressure in Taiwan Strait
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
SEC Tokenized Stock Approval Still Expected as Regulatory Framework Advances
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions
Iran Attack in Strait of Hormuz Pushes Oil Prices Higher
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
TrumpRx Expands Discount Drug Access With 600 Generic Medications 



